300 related articles for article (PubMed ID: 33782943)
1. Valproate usage in pregnancy: An audit from the Kerala Registry of Epilepsy and Pregnancy.
Seshachala BB; Jose M; Lathikakumari AM; Murali S; Kumar AS; Thomas SV
Epilepsia; 2021 May; 62(5):1141-1147. PubMed ID: 33782943
[TBL] [Abstract][Full Text] [Related]
2. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).
Thomas SV; Jeemon P; Pillai R; Jose M; Lalithakumari AM; Murali S; Sanalkumar A; Salini RA; Pavithran V
Seizure; 2021 Dec; 93():127-132. PubMed ID: 34740142
[TBL] [Abstract][Full Text] [Related]
3. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
4. Malformation in index pregnancy in women with epilepsy is not followed by recurrence in subsequent pregnancy.
Begum S; Sarma SP; Thomas SV
Epilepsia; 2013 Dec; 54(12):e163-7. PubMed ID: 24138300
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
6. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.
Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746
[TBL] [Abstract][Full Text] [Related]
7. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Harden CL; Meador KJ; Pennell PB; Hauser WA; Gronseth GS; French JA; Wiebe S; Thurman D; Koppel BS; Kaplan PW; Robinson JN; Hopp J; Ting TY; Gidal B; Hovinga CA; Wilner AN; Vazquez B; Holmes L; Krumholz A; Finnell R; Hirtz D; Le Guen C; ;
Neurology; 2009 Jul; 73(2):133-41. PubMed ID: 19398681
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications.
Jazayeri D; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE
Seizure; 2018 Mar; 56():111-114. PubMed ID: 29471258
[TBL] [Abstract][Full Text] [Related]
9. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
[TBL] [Abstract][Full Text] [Related]
10. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Harden CL; Meador KJ; Pennell PB; Hauser WA; Gronseth GS; French JA; Wiebe S; Thurman D; Koppel BS; Kaplan PW; Robinson JN; Hopp J; Ting TY; Gidal B; Hovinga CA; Wilner AN; Vazquez B; Holmes L; Krumholz A; Finnell R; Hirtz D; Le Guen C; ;
Epilepsia; 2009 May; 50(5):1237-46. PubMed ID: 19507301
[TBL] [Abstract][Full Text] [Related]
11. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy after valproate withdrawal-Fetal malformations and seizure control.
Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
Epilepsia; 2020 May; 61(5):944-950. PubMed ID: 32314363
[TBL] [Abstract][Full Text] [Related]
13. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
15. Teratogenesis in repeated pregnancies in antiepileptic drug-treated women.
Vajda FJ; O'Brien TJ; Lander CM; Graham J; Roten A; Eadie MJ
Epilepsia; 2013 Jan; 54(1):181-6. PubMed ID: 22882134
[TBL] [Abstract][Full Text] [Related]
16. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
17. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.
Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ
J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862
[TBL] [Abstract][Full Text] [Related]
18. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: An observation study in northwest China.
Shi X; Wang Y; Zhang Y; Song C; Jiang Y; Zhao J; Xia L; Ma L; Jiang W
Epilepsy Behav; 2022 Oct; 135():108904. PubMed ID: 36095876
[TBL] [Abstract][Full Text] [Related]
20. Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both?
Keni RR; Jose M; Sarma PS; Thomas SV;
Neurology; 2018 Feb; 90(9):e790-e796. PubMed ID: 29429975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
